Literature DB >> 17572415

Massive blood transfusion and trauma resuscitation.

Biswadev Mitra1, Alfredo Mori, Peter A Cameron, Mark Fitzgerald, Alison Street, Michael Bailey.   

Abstract

AIMS: To review the massive transfusion practice at a Level I adult Trauma Centre during initial trauma reception and resuscitation.
METHODS: All trauma patients presenting to The Alfred Emergency & Trauma Centre and receiving a transfusion of five units or more of packed red blood cells within 4h of presentation over a 26-month period were included in this study. Patient demographics, clinical characteristics, injuries, surgical management and volume of blood transfused were analysed with mortality as the primary endpoint. Initial clinical features and injuries predictive of massive transfusion were also analysed.
RESULTS: There were 119 patients who received a transfusion of five units or more of packed red blood cells (PRBCs) within 4h of presentation. The median Injury Severity Score of this group of patients was 34.0 (IQR 26-48) and mortality was 27.7%. The median number of packed red blood cell transfused was 8.0 (IQR 6-14) in the 1st 4h. Initial clinical features and injuries independently associated with a larger volume of blood transfused were initial hypotension, fractures of the pelvis, kidney injuries, initial acidaemia, and thrombocytopaenia. The Injury Severity Score, initial coagulopathy measured by APTT and the presence of head injuries were the independent predictors of mortality.
CONCLUSIONS: The volume of blood transfused during trauma resuscitation was not found to be an independent predictor of mortality. Prospective studies into transfusion practice and clinical features of patients during the trauma resuscitation phase requiring massive transfusion are needed to establish evidence-based guidelines for massive transfusion.

Entities:  

Mesh:

Year:  2007        PMID: 17572415     DOI: 10.1016/j.injury.2007.03.021

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  7 in total

1.  The role of trauma scoring in developing trauma clinical governance in the Defence Medical Services.

Authors:  R J Russell; T J Hodgetts; J McLeod; K Starkey; P Mahoney; K Harrison; E Bell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-01-27       Impact factor: 6.237

2.  Determinants of mortality in trauma patients following massive blood transfusion.

Authors:  Kanchana Rangarajan; Arulselvi Subramanian; Ravindra Mohan Pandey
Journal:  J Emerg Trauma Shock       Date:  2011-01

3.  Hemostatic function and transfusion efficacy of apheresis platelet concentrates treated with gamma irradiation in use for thrombocytopenic patients.

Authors:  Mei Zhu; Wei Xu; Bao-Long Wang; Hong Su
Journal:  Transfus Med Hemother       Date:  2014-05-22       Impact factor: 3.747

4.  Improving decision making for massive transfusions in a resource poor setting: a preliminary study in Kenya.

Authors:  Elisabeth D Riviello; Stephen Letchford; Earl Francis Cook; Aaron B Waxman; Thomas Gaziano
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

5.  Prediction of Massive Transfusion in Trauma Patients with Shock Index, Modified Shock Index, and Age Shock Index.

Authors:  Cheng-Shyuan Rau; Shao-Chun Wu; Spencer C H Kuo; Kuo Pao-Jen; Hsu Shiun-Yuan; Yi-Chun Chen; Hsiao-Yun Hsieh; Ching-Hua Hsieh; Hang-Tsung Liu
Journal:  Int J Environ Res Public Health       Date:  2016-07-05       Impact factor: 3.390

6.  Association between the plasma-to-red blood cell ratio and survival in geriatric and non-geriatric trauma patients undergoing massive transfusion: a retrospective cohort study.

Authors:  Mitsuaki Kojima; Akira Endo; Atsushi Shiraishi; Tomohisa Shoko; Yasuhiro Otomo; Raul Coimbra
Journal:  J Intensive Care       Date:  2022-01-11

7.  Alcohol-positive multiple trauma patients with and without blood transfusion: an outcome analysis.

Authors:  Manuel F Struck; Thomas Schmidt; Ralph Stuttmann; Peter Hilbert
Journal:  J Trauma Manag Outcomes       Date:  2009-03-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.